Day 13: Building Health AI for India - When 'Big Data' Misses the Point

Drug interactions are not actually a data problem. Not in India, at least. Most global health AI platforms pride themselves on vast databases, countless drug entries, and comprehensive interaction lists. And yes, scale matters. But what I've learned deeply building GoDavaii, especially on Day 13 of our public sprint, is that for India, the core challenge isn't the volume of information, but its accessibility and contextual relevance. The Reality on the Ground: Beyond the English Database Think about it: an Indian doctor often sees 40-60 patients in a single day.